Medication recall blood pressure: More than 580,000 bottles of Prazosin Hydrochloride, a commonly prescribed drug for high blood pressure, are being recalled after tests showed potentially unsafe levels of a cancer-linked impurity. The manufacturer has advised patients using the affected medication to reach out to their doctor or pharmacist for guidance.The recall, issued on October 7 by New Jersey–based Pharmaceuticals USA Inc., involves 55 batches of Prazosin Hydrochloride capsules distributed across the country. The recalled products were sold in 1 mg, 2 mg, and 5 mg doses under the Teva Pharmaceuticals label.Below is the list of prescription numbers included in the FDA’s recall notice, along with medical advice on what steps to take if your medication is affected.FDA Recalls Blood Pressure Medications: Which Medicine Is Being Recalled?Teva Pharmaceuticals USA and Amerisource Health Services have both recalled certain batches of prazosin hydrochloride this month after the U.S. Food and Drug Administration (FDA) detected possible contamination. According to FDA enforcement reports, the affected capsules may contain nitrosamine impurities that exceed the limits set under the agency’s Carcinogenic Potency Categorization Approach (CPCA).Nitrosamines are a group of chemical compounds that, when present in high amounts, have been linked to an increased risk of cancer. They can form during the production or storage of certain medications.The FDA classified these recalls as Class II on October 24, indicating that while the affected drugs could cause temporary or reversible health effects, the likelihood of severe harm is considered low.Current Blood Pressure Medication Recall: Which Lot Are Affected?The recall applies only to the 1 mg, 2 mg, and 5 mg capsules of prazosin hydrochloride distributed by Teva Pharmaceuticals USA and Amerisource Health Services. It affects select batches identified by specific lot numbers and expiration dates. The majority of the recalled supply, over 580,000 bottles, came from Teva, with the remainder distributed by Amerisource. Details on the affected products, including the complete list of lot codes and expiry information, are available in the FDA’s official enforcement reports.As reported by USA Today, the recall includes several dosages and packaging of the medication:1 mg capsules: 181,659 bottles (NDC 0093-4067-01 and 0093-4067-10), from lot numbers 3010544A and 3010545A, with an expiration date of October 2025.2 mg capsules: 291,512 bottles (NDC 0093-4068-01 and 0093-4068-10) from multiple lots, expiring between October 2025 and July 2026.5 mg capsules: 107,673 bottles (NDC 0093-4069-01, 0093-4069-52, and 0093-4069-05) from several batches, with expiration dates extending into 2026.What To Do If You Have The Recalled Blood Pressure Pills?If you have any of the recalled prazosin hydrochloride capsules, the FDA recommends contacting your doctor or pharmacist before stopping the medication. In some cases, discontinuing treatment without medical supervision could pose greater health risks than continuing it.Teva Pharmaceuticals has urged patients to check with their pharmacy to confirm whether their medication is part of the recall and to follow the instructions provided for returning or disposing of the affected pills. The company has already issued recall letters to its customers detailing the process.Teva noted that no complaints have been reported so far related to the recalled batches. The company added that prazosin, which is used to manage high blood pressure, has several alternative treatments available. “Teva prioritizes patient safety and product quality at every stage of a medicine’s lifecycle,” the statement read.Patients who have concerns or need further guidance are advised to speak with their prescribing healthcare provider.
Email
Google
Facebook Email Google Facebook